Advertisement

Goal 3: Increase the extent to which health-system pharmacists actively apply evidence-based methods to the improvement of medication therapy.

Revised December 20, 2005

Objective 3.1

For 100% of health-system patients, pharmacists will be actively involved in ensuring that they receive evidence-based medication therapy.

Baseline: 74.2%

Crosswalk Resources

  1. JCAHO (MM.2.1, MM.3.1, MM.8.1)
  2. Center for Education and Research on Therapeutics (CERTS)External Link
  3. National Guideline Clearinghouse (NGC)External Link
  4. Agency for Health Research & Quality (AHRQ)External Link
  5. Cochrane CollaborationExternal Link
  6. National Library of MedicineExternal Link
  7. Supporting Literature - References 1, 39 [PDF]

Objective 3.2

In 100% of health systems, pharmacists will be actively involved in the development and implementation of all evidence-based therapeutic protocols involving medication use.

Baseline:  95.3% (95% CI, 92.6–97.0%)

Crosswalk Resources

  1. JCAHO (MM.2.1)
  2. Supporting Literature - References 1, 34, 38, 39 [PDF]  

Objective 3.3

90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction or congestive heart failure will receive angiotensin-converting enzyme inhibitors or angiotensin receptor blockers at discharge.

Baseline: 19.7% (95% CI, 15.9–24.0%)

Crosswalk Resources

  1. CMS/JCAHOExternal Link (revised measure)
  2. Core Measures External Link
  3. American College of CardiologyExternal Link
  4. American Heart AssociationExternal Link
  5. National Committee for Quality AssuranceExternal Link
  6. IOMExternal Link
  7. Supporting Literature - References 1, 13, 14, 40-45  [PDF]  

Objective 3.4

90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction will receive beta-blockers at discharge.

Baseline: 17.2% (95% CI, 13.7–21.4%)

Crosswalk Resources

  1. Core MeasuresExternal Link
  2. American College of CardiologyExternal Link
  3. American Heart AssociationExternal Link
  4. National Committee for Quality AssuranceExternal Link
  5. IOMExternal Link
  6. Supporting Literature - References 1, 40, 41, 43, 45-47 [PDF]

Objective 3.5

90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction will receive aspirin at discharge.

Baseline: 18.1% (95% CI, 14.5–22.5%)

Crosswalk Resources

  1. Core MeasuresExternal Link
  2. American College of CardiologyExternal Link
  3. American Heart AssociationExternal Link
  4. IOMExternal Link
  5. Supporting Literature - References 1, 40, 41, 45, 48, 49 [PDF]   

Objective 3.6

90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction will receive lipid-lowering therapy at discharge.

Baseline: 10.5% (95% CI, 7.8–13.9%)

Crosswalk Resources 

  1. Core MeasuresExternal Link
  2. National Cholesterol Education ProgramExternal Link
  3. National Committee for Quality AssuranceExternal Link
  4. American Diabetes AssociationExternal Link
  5. Supporting Literature - Reference 1, 26, 41, 50-54 [PDF]

Objective 3.7

90% of health-system pharmacies will participate in ensuring that nonhospitalized patients who are receiving medications to decrease blood glucose levels will be assessed annually with a HbA1c test.

Baseline: 3.9% (95% CI, 2.3-6.7%)

Note: 23.5% of hospitals have such a program (95% CI, 18.6-29.3%), but only 16.17% (95% CI, 9.6-27.6%) have pharmacy participation.

Crosswalk Resources

  1. American Diabetes AssociationExternal Link
  2. American Association of Clinical  EndocrinologistsExternal Link
  3. National Committee for Quality AssuranceExternal Link
  4. Supporting Literature - References 11, 55-57 [PDF]

 
Advertisement